"The
Report Alpha- Antitrypsin Deficiency Global Clinical Trials Review,
H2, 2016 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's
clinical trial report, Alpha- Antitrypsin Deficiency Global Clinical
Trials Review, H2, 2016" provides an overview of Alpha-
Antitrypsin Deficiency clinical trials scenario. This report provides
top line data relating to the clinical trials on Alpha- Antitrypsin
Deficiency. Report includes an overview of trial numbers and their
average enrollment in top countries conducted across the globe. The
report offers coverage of disease clinical trials by region, country
(G7 & E7), phase, trial status, end points status and sponsor
type. Report also provides prominent drugs for in-progress trials
(based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
View Report @
http://www.marketresearchreports.biz/analysis/909367
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/909367
Table
of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average
Enrollment by Country 7
Top Countries Contributing to
Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to
Clinical Trials in Europe 10
Top Countries Contributing to
Clinical Trials in North America 11
Top Countries Contributing to
Clinical Trials in Central and South America 12
Clinical Trials by G7 Countries:
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders
Clinical Trials 13
Clinical Trials by Phase in G7
Countries 14
Clinical Trials in G7 Countries by
Trial Status 15
Clinical Trials by E7 Countries:
Proportion of Alpha- Antitrypsin Deficiency to Genetic Disorders
Clinical Trials 16
Clinical Trials by Phase in E7
Countries 17
Clinical Trials in E7 Countries by
Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point
Status 22
Subjects Recruited Over a Period
of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials 26
Prominent Drugs 28
Latest Clinical Trials News on
Alpha- Antitrypsin Deficiency 29
Dec 02, 2016: The Lancet
Respiratory Medicine Publishes RAPID Extension Study Data on Effect
of Zemaira [Alpha1-Proteinase Inhibitor (Human)] in Patients with
Alpha-1 Antitrypsin Deficiency 29
Nov 14, 2016: Arrowhead
Pharmaceuticals Presents New Data on ARC-AAT 29
Oct 20, 2016: Arrowhead
Pharmaceuticals to Present Data on ARC-AAT at The Liver Meeting 30
Clinical Trial Profile Snapshots
31
Appendix 58
Abbreviations 58
Definitions 58
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Read our latest Press Release
at http://www.marketresearchreports.biz/pressreleases
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment